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Abstract 
Background: Morbidity following coronary artery bypass graft (CABG) surgery is 
difficult to predict and leads to increased healthcare costs. We hypothesised that pre-
operative cardiac magnetic resonance (CMR) findings would predict resource utilisation 
in elective CABG. 
Methods: Over a 12-month period, elective CABG patients were invited to undergo CMR 
one day prior to CABG. Gadolinium-enhanced CMR was performed using a trueFISP 
inversion recovery sequence on 1.5 tesla scanner (Sonata, Siemens). Clinical data were 
prospectively collected. Admission costs were quantified based on standardised actual 
cost-per-day. Admission cost > median was defined as "increased". 
Results: Of 458 elective CABG cases, 45 (10%) underwent pre-operative CMR. Pre-
operative characteristics (mean (standard deviation) age 64 (9) years), mortality (1%) and 
admission duration (median (interquartile range 7 (6, 8) days) were similar in patients 
who did or did not undergo CMR. In the CMR patients, eight (18%) and 11 (24%) 
patients had reduced left ventricular (LV) systolic function by CMR (LVEF<55%) and 
echocardiography, respectively. Late enhancement (LE) with gadolinium was detected in 
17 (38%) patients. The average cost-per-day was $2,723. The median (range) admission 
cost was $19,059 ($10,891 to $157,917). CMR LVEF (OR [95%CI] 0.93 [0.87 to 0.99]; 
p=0.03) and stroke volume index (1.07 (1.00 to 1.14); p=0.02) predicted increased 
admission cost. CMR LVEF (p=0.08) and EuroScore tended to predict actual admission 
cost (p=0.09), but SV by CMR (p=0.16) and LV function by echocardiography (p=0.95) 
did not. 
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.  
Discussion: In this exploratory investigation, preoperative CMR findings predicted 
admission duration and increased admission cost in elective CABG. The cost-
effectiveness of CMR for risk stratification in elective CABG merits prospective 
assessment. 
Keywords: coronary artery disease; magnetic resonance imaging; coronary artery bypass 
surgery; resource utilisation 
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Introduction 
Quality of care and resource utilisation have increasing importance in cardiovascular 
healthcare provision.[1] Coronary artery bypass grafting (CABG) is an effective but 
expensive treatment.[2-5] Despite low mortality rates following elective CABG,[2;6] 
post-operative morbidity is fairly common, leading to prolonged hospital admission and 
increased resource utilisation.[7-9]  
Hospitalization costs are the leading cause for direct healthcare expenditure.[3;5;10] In 
cardiac surgery, predicting prolonged admission is notoriously difficult,[11;12] and risk 
assessment tools for morbidity [13] and mortality [12] place emphasis on unstable, high-
risk characteristics. Consequently, prediction of admission duration and costs may be less 
reliable in lower-risk patients who represent the majority of CABG cases.[2]  
Cardiac magnetic resonance (CMR) has high tissue contrast and spatial resolution, and 
has become the gold standard technique for assessment of cardiac structure and 
function.[14-16] Despite widespread availability, pre-operative CMR is usually not 
requested, and this is probably because of conventional reliance on echocardiography. 
However, compared with CMR, echocardiography is less accurate and provides no 
information on viability, and acoustic limitations are fairly common.[14]   
Information about the utility of CMR for the prediction of in-hospital outcomes in 
elective (low risk) CABG is lacking.  We hypothesised that CMR findings prior to 
CABG would correlate with post-operative morbidity and predict resource utilisation. 
Specifically, we investigated the following questions. First, could late enhancement (LE) 
with gadolinium be feasible as part of a routine assessment in low-risk patients prior to 
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elective CABG. Second, which characteristics, including those obtained from CMR, 
correlate with in-hospital outcomes? Third, do CMR findings predict resource utilisation? 
To answer these questions, CMR was performed in a representative subset of patients 
undergoing elective CABG over a 12-month period.  
Methods 
Patients with multivessel coronary artery disease (CAD) undergoing elective CABG  
were invited to participate and gave informed consent. Patients undergoing CABG 
combined with valve surgery were not included. There were no other exclusion criteria.  
One – two CMR studies took place per week over a twelve month period. Limitations in 
MR scanner availability due to other research activity precluded inclusion of more 
patients. MR data were not intended to guide clinical management. Clinical data were 
obtained from hospital electronic databases. Hospital costs were quantified based on 
actual standardised Scottish National Health Service (2005) costs per cardiac surgical bed 
day. This study was approved by the North Glasgow University Hospitals NHS Trust 
Ethics Committee. 
CMR image acquisition - pre-gadolinium contrast imaging
CMR was performed with a 1.5 tesla scanner (Sonata, Siemens, Erlangen, Germany) one 
day prior to CABG according to previously reported methods.[17] Fast imaging at steady 
state free precession cines (TrueFISP by Siemens) were used throughout for all pre-
gadolinium cines. The images were first acquired in a long axis plane (vertical long axis, 
horizontal long axis, and left ventricular (LV) outflow tract) followed by sequential short 
axis LV cine loops from the atrioventricular ring to the LV apex. 
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Pre-gadolinium imaging parameters, which were standardised for all subjects, included:  
Repetition time 3.2 ms, echo time 1.6 ms, flip angle 20°, field of view 276 mm x 
340 mm, pixel dimensions 2.0 mm x 1.3 mm. Eight millimeter imaging slices were used 
with a 2 mm interslice gap.  
CMR image analysis – pre-gadolinium  
LV images were analysed using dedicated software (Argus VA60C 2004, Siemens, 
Erlangen, Germany). Individual scans were coded by number and analysed in batches. 
Investigators were blinded to patient characteristics and in-hospital outcomes following 
CABG. LV volumes [LV end-diastolic volume (LVEDV) and LV end-systolic volume 
(LVESV)] were determined by manual planimetry of selected short axis (SA) images, as 
described previously.[17-19] Particular methodological points of note included the 
deliberate inclusion of trabeculations and papillary muscles in all analyses.[19] The most 
basal ventricular slice was identified visually and then cross-referenced with the 
horizontal long axis view before its inclusion in the final analysis to ensure this slice was 
indeed ventricular and not atrial.  
Two observers (C.B.; L.Z.) evaluated LV dimensions and function. In a subset of 10 
patients, the inter-observer correlations were: end-diastolic volume, r=0.87,p=0.002; end-
systolic volume, r=0.86,p=0.003; SV, r=0.83,p=0.005, and LV mass r=0.85,p=0.004.  
According to CMR, a reduced LVEF was defined as < 55%.[20] LV dimensions were 
indexed to body surface area.[21] 
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Gadolinium contrast enhanced-CMR image acquisition 
All patients underwent dynamic gadolinium-enhanced CMR. Gadolinium imaging was 
performed by injection of gadolinium-diethylene triaminepentaacetic acid at a dose of 0.2 
mmol/kg followed 10 minutes later by SA stack image acquisition with a gadolinium-
sensitive inversion recovery technique [Siemens inversion recovery TurboFLASH (fast 
low angle shot)] and identical slice positions as the pre-gadolinium cines.[22] 
Standardised scan settings were used for CMR in all subjects:
Repetition time 11.6 ms, echo time 4.3 ms, flip angle 20°, pixel dimensions 2.2 x 1.3 x 8 
mm/ number of segments 23. Eight millimeter imaging slices were used with a 2 mm 
interslice gap. The TurboFLASH inversion time was optimised on an individual patient 
basis. Successful nulling of normal myocardium was deemed to have been achieved once 
the LV myocardium appeared black and homogenous. An inversion time between 240 
and 280 ms was required to achieve this. Artefacts on the LE images were excluded by 
the acquisition of ‘swapped phase’ images through slice planes which appeared to 
demonstrate intramyocardial gadolinium enhancement. This technique involves the 
‘swapping’ of the phase-encoding and frequency-encoding directions, as the phase-
encoding direction is particularly prone to artefacts caused by cardiac or chest wall 
movement. 
Gadolinium contrast enhanced-CMR image analyses 
Our approach to LE analyses methods have been recently described in detail.[23] Briefly, 
LE was defined as an area of visually identified gadolinium enhancement with a mean 
signal intensity (SI) that was more than one standard deviation higher than the mean SI of 
an adjacent area of reference myocardium, which although nulled had a mean SI 
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significantly above zero. LE volume was determined by planimetry of any areas of 
gadolinium enhancement meeting these criteria. LE mass was calculated by multiplying 
gadolinium enhancement volume by myocardial density (1.05 g/cm3) and is used in the 
subsequent correlations and discussion as the absolute measured value of gadolinium 
enhancing tissue seen. 
Regional LV hypoperfusion on first-pass was visually assessed and documented using a 
16 segment model. A first-pass perfusion score (FPS) was determined according to the 
method of Baks et al.[24] Each segment was evaluated and scored as 1) normal 
enhancement 2) < 30% wall thickness subendocardial hypoenhancement or 3) > 30% 
hypoenhancement. Infarct size was defined as an area of LE. Persistent microvascular 
obstruction (PMO) was defined as an area of reduced signal intensity within an area of 
LE.[25-27] Infarct size and PMO were quantified on the 3D-volume by manual 
delineation of the enhanced and unenhanced myocardium with different contours (Argus 
software, Siemens, Germany) and expressed as a percentage of LV mass.[23;25;26] PMO 
was included in the infarct size quantification.  
Echocardiography 
Echocardiograms were performed by experienced technicians and reports were issued by 
cardiologists. Reduced LV systolic function was defined as a left ventricular ejection 
fraction < 0.40 or a qualitative report of depressed LV systolic function (mild, moderate 
or severe), which is the standard reporting method in our service.[28] Echocardiograms 
were performed within 2 months of surgery. 
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Statistical analyses 
We hypothesised that subtle abnormalities in LV function detected by CMR would be 
associated with prolonged admission duration > 7 days. With 22 subjects in each group 
(admission duration, normal vs. prolonged), a mean between group difference in LVEF 
of 10% (SD of 10%), could be detected with 90% power assuming a Type I error of 0.05.  
The distribution of all continuous data were visually inspected on a Normal plot. 
Normality was confirmed or excluded using the Shapiro-Francia test. Mean (SD) values 
and medians (interquartile range) were calculated for normally and non-normally 
distributed data, respectively. Correlations between normally and non-normally 
distributed variables were tested by Pearson's or Spearman's rho tests, respectively. All 
tests were two-tailed.  
Increased admission duration was taken to represent one week or more, consistent with 
the median duration of admission which was 7 days. For resource utilisation, the total 
admission cost was calculated by multiplying the average-cost-per day for cardiac 
surgery in the Western Infirmary (2005) by individualised length of stay. A currency 
exchange rate of £1: $1.90 was used to estimate costs in US dollars. 
Predictors of admission cost and increased admission cost were assessed using simple 
and logistic regression models, including in the subset of patients with LE (n=17). For the 
univariate models, the coefficient of variation (continuous data) and odds ratio 
(categorical data) for a given increment of the covariate are reported along with 95% 
confidence intervals (CI) and the associated P-value.  
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A significance level of 5% was used in all tests. No adjustment was made to P-values to 
account for multiple testing. All statistical analyses were performed using STATA version 
7 (Statacorp, College Station, Tx).  
Results 
All patients 
Four hundred and fifty eight elective CABG cases were performed in our center between 
April 7th, 2004 - April 19th, 2005. The characteristics of these patients are presented in 
Table 1. Previous myocardial infarction (MI) and percutaneous coronary intervention 
were more frequent in the CMR group, whereas operative risk tended to be higher in the 
non-CMR group. The number of grafts, admission duration, and mortality were similar. 
CMR patients 
Pre-operative gadolinium-enhanced CMR was performed in 45 elective CABG patients 
with on average, 1 to 2 MR studies per week according to scanner availability (Table 2). 
Eight (18%) patients had reduced LVEF defined by CMR, whereas 11(24%) patients had 
reduced LV systolic function according to echocardiography. Only 4(9%) patients had 
reduced LV systolic function by both methods. LVEF was lower in men (61(10)%) than 
in women (73(6)%; p=0.002). LE was detected in 17(38%) patients. Six of these patients 
had evidence of PMO (mean (SD) 1.3 (0.6)%), all of whom had a clinical history of MI. 
In-hospital outcomes 
A 73 year-old diabetic man died on the 3rd post-operative day. He had a reduced pre-
operative LV EF (46%) and evidence of LE (IS 26%, PMO 2%).  
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The median (IQR) duration of admission was 7 (6, 8) days. The minimum and maximum 
admission durations were 4 to 58 days. Compared to CMR patients with a normal 
admission duration, patients with an increased admission duration (> 7 days) had a lower 
LVEF, a higher ESV index (Table 3a), and more post-operative complications (Table 
3b). Admission duration correlated with LVEF (R=-0.34; p=0.02) and tended to correlate 
with the EuroScore (R=0.22; p=0.08) and ESV index (R=0.28; p=0.06). No other clinical 
or CMR findings correlated with admission duration.  
CMR LVEF univariately predicted increased admission duration (OR (95% confidence 
interval) 0.93 (0.87 to 0.99); p=0.03), and tended to predict actual admission duration 
(coefficient of variation –0.21 (-0.44 to 0.03; p=0.08). When Euroscore was added to this 
model, then the prognostic value of CMR LVEF tended to be retained (OR 0.94 (95% CI 
0.98 to 1.005); P=0.069), whereas Euroscore did not predict this event (P=0.12). 
Resource utilisation  
The average cost-per-day was $2,723. The median (interquartile range) admission cost 
was $19,059 ($16,336, $21,782). The admission cost ranged widely from a minimum of 
$10,891 to a maximum of $157,917.  
LVEF by CMR predicted increased admission cost ((OR (95%CI) cost > median value 
0.93 (0.87 to 0.99); p=0.03) and tended to predict actual admission cost (co-efficient of 
variation (95%CI): -565.65 (-1202.48 to 71.19); p=0.08). The EuroScore tended to 
predict actual admission cost (p=0.09), but SV by CMR (p=0.16) and LV function by 
echocardiography (p=0.95) did not. 
 11
Discussion 
In this exploratory investigation, we found that CMR findings correlated with admission 
duration, and predicted resource utilisation in elective CABG. To the best of our 
knowledge, this study is the first of its kind.  
Clinical relevance 
Our findings are interesting for several reasons. First, CMR took place one day prior to 
elective CABG. It was feasible (scan time < 45 min) and uncomplicated. Second, despite 
the small sample size and low rate of post-operative complications, CMR findings, and in 
particular, LV function, correlated with admission duration. Notably, other than the 
EuroScore, no other variable correlated with admission duration. CMR LVEF retained its 
prognostic value, even when combined in a regression model with the EuroScore. Third, 
based on actual in-hospital costs, CMR predicted increased resource utilisation. Our 
observations raise the possibility that CMR could be useful for risk assessment in lower-
risk stable patients referred for CABG, with potential economic benefits.[29]  
Patients with prolonged admission had depressed cardiac function, as revealed by CMR. 
Furthermore, these patients experienced an increased frequency of post-operative 
cardiovascular complications, including atrial fibrillation, which likely contributed to 
their prolonged admission duration. Although CMR was performed in a subset of 
patients, the characteristics and in-hospital outcomes of these patients were broadly 
similar to those of all patients who underwent elective CABG during the study period. 
For CMR to be a useful risk prediction instrument, it should be performed earlier than 
was done in the present study. CMR might take place once the decision for CABG has 
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been taken. Potentially, CMR could be performed with a view to triage of risk, which in 
turn could help plan for bed availability and therefore guide the operation date. 
Alternatively, CMR could be performed much earlier in the patient journey. As stress 
perfusion CMR can inform on the presence of regional ischemia, as well as left 
ventricular function, CMR could be used as the main method for cardiac imaging to help 
guide the decision regarding revascularisation, whilst also informing on surgical risk. 
Future prospective studies will be required to evaluate these different approaches. 
Current limitations for prediction of morbidity in low-risk CABG  
Unlike prediction of mortality,[30] prediction of non-fatal post-operative complications is 
notoriously difficult.[11;12] Well-validated risk prediction instruments for in-hospital 
mortality, such as the EuroSCORE,[30] may not reliably predict post-operative 
morbidity.[12] This is particularly the case in lower-risk stable patients who represent the 
greatest proportion of CABG cases. In the present study, EuroSCORE weakly correlated 
with admission duration.  
Prolonged intensive care bed occupancy leads to substantially increased costs, including 
indirect financial losses through blocked beds and reduced surgical activity. Uncertainty 
exists about which patients may experience prolonged admissions, and despite the 
availability of risk tools to predict prolonged length of stay,[13;31-34] they are not 
consistently used to guide management. One reason for the limited utility of current risk 
instruments is the strong weighting accorded to emergency surgery.[13] Importantly, the 
absolute number of post-operative complications is probably greatest in lower-risk 
patients, in whom risk-instruments will have least positive predictive value.  
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Our study suggests CMR may represent a sensitive method for pre-operative risk 
prediction. Indeed, the fact that no other traditional prognostic characteristics, including 
LV function by echocardiography,[12;13;33] predicted admission duration, raises the 
possibility that CMR may be a more sensitive risk predictor in elective CABG than 
existing methods. Echocardiography has a lower accuracy than CMR for the assessment 
of LV systolic function,[14;29] which may explain the lack of correlation of LV function 
by echocardiography with admission duration.  
CABG, resource utilisation, and potential utility of CMR for risk prediction 
Although morbidity and mortality rates in our patients were low, admission duration was 
greater than one week in over half the patients. Consequently, admission costs ranged 
widely.  In the UK, the average cost-per-CABG in 2003 was $17,596 (Scotland), and the 
national in-hospital costs for CABG were approximately $500 million.[5] In 2003, 
expenditure in the United States for in-hospital care was $94.1 billion, of which $60 
(64%) billion was for CAD.[35] In 2005, 145,333 isolated CABGs were performed, and 
the mean post-procedure length of stay was 6.9 days.[3] Average CABG costs in selected 
US and Canadian hospitals (1997 – 2001) were $20,673 and $10,373, respectively 
(P<0.001).[4]  
In this context, the incremental unit cost of CMR compared with echocardiography 
(approximately $1000 [14] is modest. Consequently, preoperative imaging and risk 
assessment by CMR has the potential to be a cost-effective strategy should CMR-based 
management lead to reductions in peri-operative complications. Importantly, CMR also 
provides quantitative information on reversible myocardial ischemia, viability, infarct 
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size, and thoracic pathology, all of which may be useful in the evaluation and 
management of patients being considered for revascularization.  
Conclusions 
LV function measured by CMR prior to elective CABG correlates with admission 
duration and predicts increased resource utilisation. CMR may be a more sensitive tool 
for risk assessment than conventional approaches in this setting. Since preoperative 
cardiac imaging is mandatory, we suggest the modest additional cost of CMR, compared 
with echocardiography, may potentially be offset by reduced resource utilisation. 
Although exploratory in nature, our observations raise the possibility that CMR prior to 
elective CABG coupled with targeted risk-reduction measures could lead to reduced 
resource utilisation. This hypothesis is in-line with contemporary healthcare 
recommendations,[1] and merits prospective assessment.  
Acknowledgements 
This work was funded by the British Heart Foundation Chair and Programme Grant 
British Heart Foundation PG/02/128 and the Wellcome Trust Cardiovascular Functional 
Genomics Initiative 066780/2/012 to AFD. LUZ was supported by the Swiss National 
Science Foundation (PBBSB-105860)/Lichtenstein-Stiftung Basel. CD was supported by 
a personal fellowship from the Deutsche Forschungsgemeinschaft (DE 826/1-1). The 
sponsors had no role in study design, data collection, data analysis, data interpretation, or 
viewing of the report. The corresponding author has final responsibility for manuscript 
submission. We would like to thank Mrs Margaret Kinnaird, and Drs Tom Martin, Robin 
Weir, and Paddy Mark for guidance on CMR analyses.  
 15
References 
 
 1.  Gibbons RJ (2007) Leading the Elephant Out of the Corner: The Future of Health 
Care: Presidential Address at the American Heart Association 2006 Scientific 
Sessions. Circulation 115, 2221-30 
 2.  Ferguson TB, Hammill BG, Peterson ED, DeLong ER, Grover FL (2002) A decade 
of change - Risk profiles and outcomes for isolated coronary artery bypass grafting 
procedures, 1990-1999: A report from the STS National Database Committee and 
the Duke Clinical Research Institute. Ann. Thorac. Surg. 73, 480-9 
 3.  Rosamond W, Flegal K, Friday G et al (2007) Heart disease and stroke statistics - 
2007 update - A report from the American Heart Association Statistics Committee 
and Stroke Statistics Subcommittee. Circulation 115, E69-E171 
 4.  Eisenberg MJ, Filion KB, Azoulay A, Brox AC, Haider S, Pilote L (2005) 
Outcomes and cost of coronary artery bypass graft surgery-in the United States and 
Canada. Arch. Int. Med. 165,1506-13 
 5.  British Heart Foundation. Heart Statistics (2006) Treatment (pages 61-77). British 
Heart Foundation, London, UK 
 6.  Pell JP, Walsh D, Norrie J et al (2001) Outcomes following coronary artery bypass 
grafting and percutaneous transluminal coronary angioplasty in the stent era: a 
 16
prospective study of all 9890 consecutive patients operated on in Scotland over a 
two year period. Heart 85, 662-6 
 7.  Lassnigg A, Hiesmayr MJ, Bauer P, Haisjackl M (2002) Effect of centre-, patient- 
and procedure-related factors on intensive care resource utilisation after cardiac 
surgery. Intensive Care. Med. 28, 1453-61 
 8.  Hein OV, Birnbaum J, Wernecke K, England M, Konertz W, Spies C (2006) 
Prolonged intensive care unit stay in cardiac surgery: Risk factors and long-term-
survival. Ann. Thorac. Surg. 81, 880-5 
 9.  Higgins TL (1998) Quantifying risk and assessing outcome in cardiac surgery. J 
Cardiothorac. Vasc. Anesth. 12, 330-40 
 10.  Berry C, Murdoch DR, McMurray J (2001) Economics of chronic heart failure Eur. 
J. Heart. Fail. 3, 283-91 
 11.  Tu JV, Mazer CD (1996) Can clinicians predict ICU length of stay following 
cardiac surgery? Can. J. Anaesth. 43, 789-94 
 12.  Geissler HJ, Holzl P, Marohl S et al. (2000) Risk stratification in heart surgery: 
comparison of six score systems. Eur. J. Cardiothorac. Surg. 17, 400-5 
 17
 13.  Tu JV, Mazer CD, Levinton C, Armstrong PW, Naylor CD (1994) A predictive 
index for length of stay in the intensive-care unit following cardiac-surgery. Can. 
Med. Assoc. J 151, 177-85 
 14.  Pennell DJ, Sechtem UP, Higgins CB et al. (2004) Clinical indications for 
cardiovascular magnetic resonance (CMR): Consensus Pane report. Eur. Heart. J. 
25, 1940-65 
 15.  Schvartzman PR, Srichai MB, Grimm RA et al. (2003) Nonstress delayed-
enhancement magnetic resonance imaging of the myocardium predicts 
improvement of function after revascularization for chronic ischemic heart disease 
with left ventricular dysfunction. Am. Heart. J. 146, 535-41 
 16.  Selvanayagam JB, Kardos A, Francis JM et al (2004) Value of delayed-
enhancement cardiovascular magnetic resonance imaging in predicting myocardial 
viability after surgical revascularization. Circulation 110, 1535-41 
 17.  Zimmerli LU, Mark PB, Steedman T et al. (2007) Vascular function in patients with 
end-stage renal disease and/or coronary artery disease: a cardiac magnetic 
resonance imaging study. Kidney. Int. 71, 68-73 
 18.  Lorenz CH, Walker ES, Morgan VL, Klein SS, Graham TP (1999) Normal human 
right and left ventricular mass, systolic function, and gender differences by cine 
magnetic resonance imaging.  J. Cardiovasc. Magn. Reson. 1, 7-21 
 18
 19.  Sievers B, Kirchberg S, Franken U, Puthenveettil BJ, Bakan A, Trappe HJ (2005) 
Visual estimation versus quantitative assessment of left ventricular ejection 
fraction: A comparison by cardiovascular magnetic resonance imaging. Am. Heart. 
J. 150, 737-42 
 20.  Alfakih K, Plein S, Bloomer T, Jones T, Ridgway J, Sivananthan M (2003) 
Comparison of right ventricular volume measurements between axial and short axis 
orientation using steady-state free precession magnetic resonance imaging. J. 
Cardiovasc. Magn. Reson. 18, 25-32 
 21.  Mosteller RD (1987) Simplified calculation of body-surface area. N. Engl. J. Med. 
317,1098 
 22.  Simonetti OP, Kim RJ, Fieno DS et al. (2001) An improved MR imaging technique 
for the visualization of myocardial infarction. Radiology 218, 215-23 
 23.  Mark PB, Johnston N, Groenning BA et al. (2006) Redefinition of uremic 
cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. Kidney 
Int. 69, 1839-45 
 24.  Baks T, van Geuns RJ, Biagini E et al. (2005) Recovery of left ventricular function 
after primary angioplasty for acute myocardial infarction. Eur. Heart J. 26, 1070-7 
 19
 25.  Hombach V, Grebe O, Merkle N et al (2005) Sequelae of acute myocardial 
infarction regarding cardiac structure and function and their prognostic significance 
as assessed by magnetic resonance imaging Eur Heart J 26, 549-57 
 26.  Lund GK, Stork A, Saeed M et al. (2004) Acute myocardial infarction: Evaluation 
with first-pass enhancement and delayed enhancement MR imaging compared with 
(TI)-T-201 SPECT imaging. Radiology 232, 49-57 
 27.  Fieno DS, Kim RJ, Chen EL, Lomasney JW, Klocke FJ, Judd RM (2000) Contrast-
enhanced magnetic resonance imaging of myocardium at risk - Distinction between 
reversible and irreversible injury throughout infarct healing. J. Am. Coll. Cardiol. 
36, 1985-91 
 28.  Berry C, Norrie JN, Hogg K, Brett M, Stevenson K, McMurray JJV (2006) The 
prevalence, nature and importance of hematologic abnormalities in heart failure. 
Am. Heart J. 151, 1513-21 
 29.  Bellenger NG, Burgess MI, Ray SG et al. (2000) Comparison of left ventricular 
ejection fraction and volumes in heart failure by echocardiography, radionuclide 
ventriculography and cardiovascular magnetic resonance - Are they 
interchangeable? Eur. Heart J. 21, 1387-96 
 20
 30.  Roques F, Nashef SAM, Michel P et al. (1999) Risk factors and outcome in 
European cardiac surgery: analysis of the EuroSCORE multinational database of 
19030 patients. Eur. J. Cardiothorac. Surg. 15, 816-22. 
 31.  Higgins TL, McGee WT, Steingrub JS, Rapoport J, Lemeshow S, Teres D (2003) 
Early indicators of prolonged intensive care unit stay: Impact of illness severity, 
physician staffing, and pre-intensive care unit length of stay. Crit. Care Med. 2003 
31, 45-51 
 32.  Nathanson B, Higgins TL, Teres D, Copes WS, Kramer A, Stark M (2005) An 
updated method to assess ICU clinical performance and resource utilization. Crit. 
Care Med. 33, A26 
 33.  Mounsey JP, Griffith MJ, Heaviside DW, Brown AH, Reid DS (1995) 
Determinants of the length of stay in intensive-care and in-hospital after coronary-
artery surgery. Br. Heart J. 73, 92-8. 
 34.  Michalopoulos A, Tzelepis G, Pavlides G, Kriaras J, Dafni U, Geroulanos S (1996) 
Determinants of duration of ICU stay after coronary artery bypass graft surgery. Br. 
J. Anaesth. 77, 208-12. 
 35.  American Heart Association. Heart Disease and Stroke Statistics: 2003 Update.  
2002. Dallas, Texas, American Heart Association.  
 21
Figure legend 
 
Figure 1. Mean (SD) left ventricular ejection fraction (LVEF) by CMR was 
higher (66 (10)%) in patients with an admission duration ≤ 7 days than in patients with an 
admission prolonged > 7 days (59 (10)%; p=0.02). The Shapiro-Francia test confirmed 
LVEF data were normally distributed (p>0.05).  
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Table 1. Clinical characteristics of elective CABG patients according to 
pre-operative CMR status (yes / no). 
 
Clinical characteristics 
Pre-operative CMR 
(n=45) 
No-preoperative CMR 
(n=413) 
P 
Mean (SD) age, years 63 (9) 65 (9) 0.16 
Mean body mass index (SD), kg/m2 29 (4) 29 (4) 0.50 
Male gender, n (%) 37 (82) 319 (80) 0.7 
History of myocardial infarction, n (%) 24 (53) 164 (40) 0.08 
Diabetes, n (%) 
Non-insulin treated 
Insulin-treated  
 
3 (7) 
9 (20) 
 
21 (5) 
64 (15) 
 
0.64 
Hypertension, n (%) 31 (69) 266 (64) 0.55 
Chronic lung disease, n (%) 2 (4) 47 (11) 0.15 
Peripheral vascular disease, n (%) 1 (2) 39 (9) 0.10 
History of PCI, n (%) 5 (11) 11 (3) 0.003 
Median (interquartile range) serum 
creatinine, µmol/L 
102 (95, 113)  102 (93, 116) 0.88 
Angina grade, Canadian Cardiovascular 
Class 0 / 1 / 2 / 3 / 4; n (%) 
1 (2) / 9 (20) / 20 (44) / 
13 (29) / 2 (4) 
20 (5) / 52 (13) / 176 (43) / 
128 (31) / 37 (9) 
0.50 
New York Heart Association functional 
class I / II / III, n (%) 
14 (31) / 22 (49) / 9 (20) 95 (23) / 192 (46) / 113 
(27) / 13 (3) 
0.33 
Number of coronary artery grafts (n, %) 
1 – 2 / 3 / 4 - 5 
 
15 (33) / 25 (56) / 5 (11) 
 
88 (21) / 268 (65) / 57 (14) 
 
0.2 
Mean (SD)  
EuroScore, % 
Parsonnet risk, % 
 
2.5 (1.6) 
5 (6) 
 
3.2 (2.3) 
6 (7) 
 
0.03 
0.11 
Drug therapy 
   
Aspirin 37 (82%) 362 (88) 0.30 
Beta-blocker 39 (87%)  334 (81) 0.34 
ACE inhibitor 25 (44%)  223 (54) 0.84 
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Table 2.  Dynamic gadolinium contrast enhanced cardiac magnetic 
resonance findings. 
 
 Mean (SD) Range 
LV ejection fraction, % 64 (10) 34, 87 
End-diastolic volume index, ml/m2 72 (18) 39, 114 
End-systolic volume index, ml/m2 27 (12) 7, 62 
Stroke volume index, ml/m2 45 (11) 26, 66 
LV mass, g/m2 78 (22) 39, 125 
First pass perfusion defect 9 (20%)  
First pass perfusion score 
16 
18 – 21 
22 - 25 
 
36 (80%) 
4 (8%) 
5 (12%) 
 
Late enhancement 17 (38%)  
Number of patients with 0, 1 or 2 territories with 
transmural extent of infarction > 50, % 
0 
1 territory 
2 territories 
                         
 
0 
11 (24) 
3 (7) 
 
*Mean (SD) infarct size, % 10 (8) 1.2, 26.6 
Mean (SD) PMO, % 1.3 (0.4) 0.6, 1.7 
 
*LE was present in 17 patients, in whom 6 had evidence of persistent microvascular 
obstruction (PMO). Patients with a clinical history of MI had greater LE (11(8)%) 
compared to patients without a history of MI (3.9(3.8)%); p=0.04). 
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Table 3a. Preoperative characteristics in CMR patients according to 
admission duration ≤ or > 7 days. 
 
 Admission duration ≤ 
7 days (n=29; 64%) 
Admission duration > 
7 days (n=16; 36%) 
P  
Clinical 
   
Mean (SD) age, yrs 61 (8) 65 (10) 0.17 
Mean (SD) BMI, kg/m2  30 (4) 28 (4) 0.21 
Creatinine 103 (15) 117 (38) 0.08 
Hemoglobin 14.4 (0.9) 13.8 (0.9) 0.05 
Diseased arteries, n (%) 
2  
3 
 
12 (41) 
17 (58) 
 
5 (31) 
11 (69) 
 
 
0.50 
Estimated in-hospital mortality  
EuroScore 
Parsonnet score  
 
2 (1, 4) 
4 (3, 7) 
 
3 (2, 4) 
5.5 (2.5, 12) 
 
0.20 
 
Cardiac CMR 
   
Mean (SD) LV ejection fraction, % 66 (10) 59 (10) 0.02 
Mean (SD) end-diastolic volume index, 
ml/m2
68 (16) 78 (19) 0.09 
Mean (SD) end-systolic volume, ml 23 (11) 33 (12) 0.01 
Mean (SD) stroke volume index, ml/m2 45 (10) 45 (12) 0.87 
LV mass index, g/m2 80 (21) 75 (25) 0.44 
First pass perfusion score 17 (2) 18 (3) 0.34 
Number of territories with transmural extent 
of infarction > 50% 
0 
1 
2 
 
20 (69) 
8 (28) 
1 (3) 
 
11 (69) 
3 (18) 
2 (12) 
 
 
0.45 
Mean (SD) infarct size, % LV mass 3.5 (7.0) 4.4 (7.2) 0.70 
Mean (SD) PMO, % LV mass 0.13 (0.44) 0.25 (0.54) 0.44 
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Table 3b. Post-operative complications in CMR patients according to 
admission duration ≤ or > 7 days. 
 
 Admission duration ≤ 
7 days (n=29; 64%) 
Admission duration > 7 
days (n=16; 36%) 
P  
*Major adverse cardiac and 
cerebrovascular events 
1 (3) 1 (6) 0.66 
Atrial flutter/fibrillation 4 (14) 10 (62) 0.001 
†Infection  1 (3) 1 (6) 0.66 
Blood product transfusion 8 (28) 11 (69) 0.007 
 
*One patient had a stroke and one other patient died. †Infection was recorded if there was 
septicemia, or involvement of the leg, sternum, or mediastinum. 
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Figure 1. Ejection fraction measured by pre-operative cardiac magnetic 
resonance and admission duration. 
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